University of Birmingham The impact of bariatric surgery on incident microvascular complications in patients with type 2 diabetes

Aim: To assess the impact of bariatric surgery (BS) on incident microvascular complications [diabetes-related foot disease (DFD), sight threatening diabetic retinopathy (STDR), chronic kidney disease (CKD)] in patients with type 2 diabetes and obesity. Methods: A retrospective matched, controlled population-based cohort study of adults with type 2 diabetes between 1/1/1990 and 31/1/2018 using IQVIA Medical Research Data (IMRD), a database of primary care electronic records. Each patient with type2 diabetes who subsequently had BS (surgical) was matched on index date with up to 2 patients with type 2 diabetes did not have BS (non-surgical) within the same general practice by age, sex, pre-index body mass index and diabetes duration. Results: 1126 surgical and 2219 non-surgical participants were included. In the study population, 2261 (68%) were women; Mean (SD) age was 49.87 (9.3) vs 50.12 (9.3) years and BMI was 46.76 (7.96) kg/m 2 vs 46.14 (7.49) kg/m 2 in surgical vs non-surgical group respectively. In surgical group, 22.1%, 22.7%, 52.2% and 1.1% patients had gastric band, sleeve gastrectomy, gastric bypass & duodenal switch respectively. Over median (IQR) follow-up was 3.9 years (1.8-6.4), BS was associated with reduction in incident combined microvascular complications (adjusted HR 0.63, 95% CI 0.51 to 0.78, p<0.001), DFD (0.61, 0.50 to 0.75, p<0.001), STDR (0.66, 0.44 to 1.00, p<0.001), CKD (0.63, 0.51 to 0.78, p<0.001). Analysis based on the type of surgery showed that all types of surgery were associated with favourable impact on the incident of composite microvascular complications, greatest reduction RYGB. Conclusions: BS was associated with a significant reduction in incident diabetes-related microvascular complications.

[1]  A. Tahrani,et al.  Impact of bariatric surgery on cardiovascular outcomes and mortality: a population‐based cohort study , 2020, The British journal of surgery.

[2]  Amy S. Shah,et al.  Effect of Surgical Versus Medical Therapy on Diabetic Kidney Disease Over 5 Years in Severely Obese Adolescents With Type 2 Diabetes , 2019, Diabetes Care.

[3]  I. Idris,et al.  Effect of Bariatric Surgery on Cardiovascular Events and Metabolic Outcomes in Obese Patients with Insulin-Treated Type 2 Diabetes: a Retrospective Cohort Study , 2019, Obesity Surgery.

[4]  B. Ludvik,et al.  Albuminuria in Patients with Morbid Obesity and the Effect of Weight Loss Following Bariatric Surgery , 2019, Obesity Surgery.

[5]  G. Rutter,et al.  161-LB: Inhibition of Kidney SGLT2 Expression following Bariatric Surgery in Mice , 2019, Diabetes.

[6]  T. Taverner,et al.  Risk of Incident Obstructive Sleep Apnea Among Patients With Type 2 Diabetes , 2019, Diabetes Care.

[7]  B. Richelsen,et al.  Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study , 2019, Diabetologia.

[8]  S. Haneuse,et al.  Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care , 2018, Annals of Internal Medicine.

[9]  S. Arnold,et al.  Cardiovascular Outcomes and Mortality in Type 2 Diabetes with Associated Cardio-Renal-Metabolic Comorbidities , 2018, Diabetes.

[10]  J. Guest,et al.  Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes , 2018, International wound journal.

[11]  L. Fischer,et al.  Meta‐analysis of metabolic surgery versus medical treatment for microvascular complications in patients with type 2 diabetes mellitus , 2018, The British journal of surgery.

[12]  Krishnarajah Nirantharakumar,et al.  Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study , 2018, PLoS medicine.

[13]  B. Wolfe,et al.  Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study , 2017, JAMA surgery.

[14]  K. Truong,et al.  The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis , 2017, Obesity Surgery.

[15]  K. Toulis,et al.  All-cause mortality in patients with diabetes under glucagon-like peptide-1 agonists: A population-based, open cohort study. , 2017, Diabetes & metabolism.

[16]  K. Toulis,et al.  All-Cause Mortality in Patients With Diabetes Under Treatment With Dapagliflozin: A Population-Based, Open-Cohort Study in The Health Improvement Network Database , 2017, The Journal of clinical endocrinology and metabolism.

[17]  D. Ryan,et al.  Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over , 2017, Current Obesity Reports.

[18]  C. L. le Roux,et al.  Morbidity and mortality associated with obesity. , 2017, Annals of translational medicine.

[19]  A. Tahrani,et al.  The impact of bariatric surgery on estimated glomerular filtration rate in patients with type 2 diabetes: a retrospective cohort study. , 2016, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[20]  Lawrence A Leiter,et al.  Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. , 2016, The New England journal of medicine.

[21]  P. Heagerty,et al.  Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014. , 2016, JAMA.

[22]  T. Wadden,et al.  Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in CVD Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical Trial , 2016, Diabetes Care.

[23]  B. Wolfe,et al.  Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes , 2016, Diabetes Care.

[24]  K. Takeshita,et al.  Relationship between Neuropathic Pain and Obesity , 2016, Pain research & management.

[25]  M. Fischereder,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2016, The New England journal of medicine.

[26]  A. Tahrani,et al.  The impact of bariatric surgery on retinopathy in patients with type 2 diabetes: a retrospective cohort study. , 2016, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[27]  I. Petersen,et al.  Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study , 2016, BMJ Open.

[28]  C. Ricci,et al.  Long-Term Effects of Bariatric Surgery on Type II Diabetes, Hypertension and Hyperlipidemia: A Meta-Analysis and Meta-Regression Study with 5-Year Follow-Up , 2015, Obesity Surgery.

[29]  P. Funch‐jensen,et al.  Clinical Indications, Utilization, and Funding of Bariatric Surgery in Europe , 2014, Obesity Surgery.

[30]  C. Bouchard,et al.  Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. , 2014, JAMA.

[31]  Desmond E. Williams,et al.  Changes in diabetes-related complications in the United States, 1990-2010. , 2014, The New England journal of medicine.

[32]  D. Blackhurst,et al.  Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. , 2013, Journal of the American College of Surgeons.

[33]  P. Home,et al.  Observational Study of the Association of First Insulin Type in Uncontrolled Type 2 Diabetes with Macrovascular and Microvascular Disease , 2012, PloS one.

[34]  Josef Coresh,et al.  Chronic kidney disease , 2012, The Lancet.

[35]  B. Franklin,et al.  Differential loss of fat and lean mass in the morbidly obese after bariatric surgery. , 2010, Metabolic syndrome and related disorders.

[36]  D. Selvarajah,et al.  The Eurodiab study: What has this taught us about diabetic peripheral neuropathy? , 2009, Current diabetes reports.

[37]  A. Maguire,et al.  The importance of defining periods of complete mortality reporting for research using automated data from primary care , 2009, Pharmacoepidemiology and drug safety.

[38]  M. Fowler Microvascular and Macrovascular Complications of Diabetes , 2008, Clinical Diabetes.

[39]  Samy Suissa,et al.  Immortal time bias in pharmaco-epidemiology. , 2008, American journal of epidemiology.

[40]  D. Carey,et al.  Body Composition and Metabolic Changes following Bariatric Surgery: Effects on Fat Mass, Lean Mass and Basal Metabolic Rate: Six Months to One-Year Follow-up , 2006, Obesity surgery.

[41]  S. Wild,et al.  Risk factors for diabetes and coronary heart disease , 2006, BMJ : British Medical Journal.

[42]  Carlos Iribarren,et al.  Body Mass Index and Risk for End-Stage Renal Disease , 2006, Annals of Internal Medicine.

[43]  Thomas D. Giles,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[44]  G. Miscio,et al.  Obesity and peripheral neuropathy risk: a dangerous liaison , 2005, Journal of the peripheral nervous system : JPNS.

[45]  A. Boulton,et al.  The global burden of diabetic foot disease , 2005, The Lancet.

[46]  D. Cummings,et al.  Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery. , 2005, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[47]  Henry Buchwald,et al.  Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.

[48]  Erzo F. P. Luttmer,et al.  The Cost of Diabetes , 1989, Diabetic medicine : a journal of the British Diabetic Association.

[49]  F. Porzsolt,et al.  Using machine learning to predict laboratory test results , 2016, Annals of clinical biochemistry.

[50]  Internal Clinical Guidelines Team,et al.  Diabetic Foot Problems: Prevention and Management , 2015 .

[51]  Desmond E. Williams,et al.  Changes in diabetes-related complications in the United States. , 2014, The New England journal of medicine.

[52]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.